Barclays

Two SSA borrowers are coming to the market for euro deals on Tuesday. The European Financial Stability Facility and Erste Abwicklungsanstalt will both print what are likely to be their final benchmarks of the year.

A pair of public sector borrowers hit the dollar market this week, pulling off strong deals at three and five years. Both enjoyed a clear field as euro-based borrowers stuck to their home currency thanks to an unpalatable basis swap rate.

The European Bank for Reconstruction and Development (EBRD) focused “on price over size” but achieved both when it brought its third Sonia-linked floating rate note (FRN) to the market this week, according to one of its leads.

The Society of London, better known as Lloyd’s of London, is marketing a US private placement (PP). The insurance organisation's debut in PPs in its 333 year history is another sign the market is attracting a wider range of UK companies than ever before.

Investors staged a protest over pricing in the non-preferred senior bond market this week, causing one transaction to fail and putting two others at risk of falling flat. Comfortable with their returns for 2019 and happy to be able to choose from a glut of new bond offerings, funds have simply been happy to divert their attention elsewhere. Tyler Davies reports.

Bovis Homes hits debt and equity markets — IAG swoops on €1bn Air Europa — Northern Irish HA sells US private placements in market first

Germany’s Daimler and the UK’s SP Transmission hit the sterling market this week, bringing deals that had to ride waves caused by European Central Bank bond buying and political upheaval in the UK.

Rating: Aaa/AAA/AAA

Colgate Palmolive and Boston Scientific Corp printed €1.9bn of bonds this week, the latest US companies in the line to issue euro debt.

Technology firm Apple issued its first euro green bond on Thursday, selling a €2bn deal that bankers thought had been priced flat to its curve. The issue continued a strong recent run of Reverse Yankee deals.

UK housebuilder Bovis Homes is heading to the debt and equity markets to finance an agreed £1.075bn acquisition of part of compatriot Galliford Try’s business.

Boston Scientific Corp, the US medical devices maker, obtained plenty of demand for its €900m bond as it made its debut in the Reverse Yankee market on Wednesday, while the euro corporate bond pipeline continues to fill for a flurry of issuance in November.